Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
KTD3001 Protein Quantification Kit (BCA Assay) Neonatal sevoflurane exposure disrupted fatty acids metabolism, leading to hypomyelination and neurological impairments(KTD3001-7.5) 7.5 Oncol Lett
A21020 HRP, Goat Anti-Rabbit IgG NEP1-40 Regulates the Development of Hippocampal Neural Stem Cells in Schizophrenic Mice.(A21020-1.5) 1.5 Current Medical Science 
BMU102 NEP1-40 Regulates the Development of Hippocampal Neural Stem Cells in Schizophrenic Mice.(BMU102-1.5) 1.5 Current Medical Science 
KTB1030 CheKine™ Micro Superoxide Dismutases (SOD) Activity Assay Kit Nephroprotective effects and antioxidant mechanisms of a novel polysaccharide from Poria cocos sclerotia in chemotherapy-induced kidney injury(KTB1030-7.4) 7.4 MOLECULAR & CELLULAR PROTEOMICS
KTB1040 CheKine™ Micro Catalase (CAT) Activity Assay Kit Nephroprotective effects and antioxidant mechanisms of a novel polysaccharide from Poria cocos sclerotia in chemotherapy-induced kidney injury(KTB1040-7.4) 7.4 Materials Science and Engineering
KTB2100 CheKine™ Micro Serum Potassium (K+) Assay Kit Nephroprotective effects of honokiol in a high-fat diet-streptozotocin rat model of diabetic nephropathy(KTB2100-5.1) 5.1
A23420 Dylight 594, Goat Anti-Rabbit IgG NETs induce ferroptosis of endothelial cells in LPS-ALI through SDC-1/HS and downstream pathways(A23420-7.5) 7.5 Front Pharmacol
KTA1020 Cell Counting Kit-8 (CCK-8) Network pharmacology analysis and experimental validation of EGCG's therapeutic effects against acute lung injury in sepsis.(KTA1020-4.7) 4.7  International Immunopharmacology 
A23710 Dylight 680, Goat Anti-Mouse IgG Network pharmacology and experimental verification to explore the molecular mechanisms of Astragaloside IV against diabetic encephalopathy.(A23710-2.2) 2.2 Biochemical and Biophysical Research Communications 
A23920 Dylight 800, Goat Anti-Rabbit IgG Network pharmacology and experimental verification to explore the molecular mechanisms of Astragaloside IV against diabetic encephalopathy.(A23920-2.2) 2.2 Biochemical and Biophysical Research Communications